SynAct Pharma AB · OMXSTO:SYNACT

Quantass ApS bought 7,900 SynAct Pharma AB shares (MAR article 19 notification)

Traded Mar 5, 2026 · Filed Mar 9, 2026 · Read by 6ix Oct 14, 2026

On Mar 5, 2026, Quantass ApS (Closely associated with Jeppe Øvli Øvlesen (Chief Executive Officer (CEO)/Managing Directory)) bought 7,900 SynAct Pharma AB shares at SEK 17.99 for SEK 142K. Filed Mar 9, 2026 (MAR article 19 notification).

Bought
7,900 shares
Price
SEK 17.99
Value
SEK 142K
Role
Closely associated with Jeppe Øvli Øvlesen (Chief Executive Officer (CEO)/Managing Directory)

The register entry

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 5, 2026SynAct Pharma ABBuy7,900SEK 17.99Indirect

Source

View original at Finansinspektionen

Related